Skip to main content
Clinical Trials/NCT06019078
NCT06019078
Completed
Not Applicable

Continuous Processed Neurological Monitor to Guide the Management of Sedation for Patients Receiving Mechanical Ventilation: a Prospective Observational Study to Test the Effects on Delirium, Days on a Ventilator, and Post-Intensive Care Syndrome.

Fraser Health1 site in 1 country150 target enrollmentJanuary 31, 2024

Overview

Phase
Not Applicable
Intervention
SedLine
Conditions
Critical Illness
Sponsor
Fraser Health
Enrollment
150
Locations
1
Primary Endpoint
Delirium
Status
Completed
Last Updated
2 months ago

Overview

Brief Summary

The goal of this multi-site observational study is to compare delirium rates, days on mechanical ventilation, and Post Intensive Care Syndrome (PICS) rates in adult Intensive Care Unit (ICU) patients. The study will examine patients whose sedation and analgesia infusion titration is managed with both Richmond Agitation and Sedation Scale (RASS) and Processed Electroencephalography (pEEG) monitoring vs patients who receive RASS monitoring alone.

The main questions are:

  • Compared to RASS monitoring method alone, does the use of 4 channel pEEG monitor in conjunction with RASS to guide the management of sedation and analgesic in patients who are ventilated reduce the average number of delirium days, measured by Intensive Care Delirium Screening Checklist (ICDSC)?
  • To determine when compared to RASS monitoring alone if the use of 4 channel pEEG monitor in conjunction with RASS to guide the management of Intravenous (IV) sedation and analgesia in ventilated patients reduces the days a patient spends on a mechanical ventilator when compared to RASS only monitoring from retrospective data.
  • To determine when compared to RASS monitoring method alone, does the use of 4 channel pEEG monitor in conjunction with RASS experience lower doses of sedation and analgesia infusions?
  • To determine when compared to RASS monitoring method alone, does the use of 4 channel pEEG monitor in conjunction with RASS experience less incidence and duration of PICS?

Detailed Description

The purpose of this study is to determine the impact of using a 4 channel pEEG monitor to guide sedation and analgesia management in conjunction with RASS in ventilated patients in the ICU on length of time patients experience delirium, number of days patients spend on a ventilator, and incidence of PICS in these same patients. Participants who are on a mechanical ventilator and on IV sedation or analgesia will be placed on a pEEG monitor on admission to ICU. Participants will complete a battery of test at discharge, one month post discharge, and three months post discharge to assess for PICS.

Registry
clinicaltrials.gov
Start Date
January 31, 2024
End Date
December 30, 2025
Last Updated
2 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Fraser Health
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Admitted to ICU
  • Receive mechanical ventilator support during ICU stay
  • Require IV sedation or analgesic while ventilated
  • Discharged home from the hospital
  • Use of pEEG for sedation or analgesic titration
  • Able to read and speak English
  • Mechanically ventilated greater than 48 hours
  • Aged 17 years +1 day or greater
  • Consent to participate
  • Participants need a computer with a keyboard, internet access, and email access for the questionnaires and assessment and be able to use computer and internet.

Exclusion Criteria

  • Deceased during hospitalization
  • Intubated at a hospital not included within the study \> 12 hours
  • Discharge to rehabilitation facility, long term care, or other outpatient setting
  • Inability to provide informed consent
  • Currently enrolled in any other research study involving drugs or devices
  • Is unable to be screened for delirium during ICU admission.

Arms & Interventions

Prospective Cohort

Patients admitted to participating ICUs who meet inclusion criteria monitored by 4 channel pEEG.

Intervention: SedLine

Retrospective Cohort

Patients admitted to participating ICUs who meet inclusion criteria not monitored by 4 channel pEEG.

Outcomes

Primary Outcomes

Delirium

Time Frame: For the time the patient remains in ICU until discharge from ICU. Average length of stay in ICU is 7 days.

Measured by Intensive Care Delirium Screening Checklist (ICDSC). The items include the assessment of: (1) consciousness ( deep sedation/coma, agitation, normal wakefulness, or light sedation); (2) inattention; (3) disorientation; (4) hallucination, delusion, or psychosis; (5) psychomotor agitation or retardation; (6) inappropriate speech or mood; (7) sleep-wake cycle disturbances; and (8) fluctuation of symptomatology. The maximum score is eight; scores of ≥4 indicate the presence of delirium and score zero is indicate not in delirium. Each item is scored 0-8.

Secondary Outcomes

  • Computerized Neurocognitive Screening Vital Signs(At hospital discharge (4 days +/- 1) average length of stay in hospital 5-90 days, 1 month post discharge, 3 months post discharge)
  • Sedation Infusions (Propofol and/or Midazolam)(Measured every 4 hours while the patient remains on the infusion in ICU. Average length of time spent on a sedation infusion is 5 days.)
  • Suppression Ratio(From the time pEEG monitoring is initiated until it is discontinued. Average length of time spent on a pEEG monitor is 5 days.)
  • Days of Mechanical Ventilation(From the date of intubation until extubation in ICU. Average length of mechanical ventilation is 7 days.)
  • Combined Sedation and Analgesia Infusions (Dexmedetomidine and/or Ketamine)(Measured every 4 hours while the patient remains on the infusion in ICU. Average length of time spent on a combined sedation and analgesic infusion is 3 days.)
  • Analgesia Infusions (Fentanyl, Morphine, and/or Hydromorphone)(Measured every 4 hours while the patient remains on the infusion in ICU. Average length of time spent on an analgesic infusion is 5 days.)
  • Impact of Events Scale-Revised(At hospital discharge (4 days +/- 1) average length of stay in hospital 5-90 days, 1 month post discharge (6 days +/- 1) , 3 months post discharge (6 days +/- 1))
  • EuroQol-5D-5L(At hospital discharge (4 days +/- 1) average length of stay in hospital 5-90 days, 1 month post discharge (6 days +/- 1) , 3 months post discharge (6 days +/- 1))
  • Hospital Anxiety and Depression Scale(At hospital discharge (4 days +/- 1) average length of stay in hospital 5-90 days, 1 month post discharge (6 days +/- 1) , 3 months post discharge (6 days +/- 1))

Study Sites (1)

Loading locations...

Similar Trials